Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, Aichour AN, Aichour I, Aichour MTE, Alam K, Alam N, et al. (2017)
LANCET RESPIRATORY MEDICINE 5(9): 691-706.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ; ;
Alle
Abstract / Bemerkung
Background Chronic obstructive pulmonary disease (COPD) and asthma are common diseases with a heterogeneous distribution worldwide. Here, we present methods and disease and risk estimates for COPD and asthma from the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2015 study. The GBD study provides annual updates on estimates of deaths, prevalence, and disability-adjusted life years (DALYs), a summary measure of fatal and non-fatal disease outcomes, for over 300 diseases and injuries, for 188 countries from 1990 to the most recent year. Methods We estimated numbers of deaths due to COPD and asthma using the GBD Cause of Death Ensemble modelling (CODEm) tool. First, we analysed data from vital registration and verbal autopsy for the aggregate category of all chronic respiratory diseases. Subsequently, models were run for asthma and COPD relying on covariates to predict rates in countries that have incomplete or no vital registration data. Disease estimates for COPD and asthma were based on systematic reviews of published papers, unpublished reports, surveys, and health service encounter data from the USA. We used the Global Initiative of Chronic Obstructive Lung Disease spirometry-based definition as the reference for COPD and a reported diagnosis of asthma with current wheeze as the definition of asthma. We used a Bayesian meta-regression tool, DisMod-MR 2.1, to derive estimates of prevalence and incidence. We estimated population-attributable fractions for risk factors for COPD and asthma from exposure data, relative risks, and a theoretical minimum exposure level. Results were stratified by Socio-demographic Index (SDI), a composite measure of income per capita, mean years of education over the age of 15 years, and total fertility rate. Findings In 2015, 3.2 million people (95% uncertainty interval [UI] 3.1 million to 3.3 million) died from COPD worldwide, an increase of 11.6% (95% UI 5.3 to 19.8) compared with 1990. There was a decrease in age-standardised death rate of 41.9% (37.7 to 45.1) but this was counteracted by population growth and ageing of the global population. From 1990 to 2015, the prevalence of COPD increased by 44.2% (41.7 to 46.6), whereas age-standardised prevalence decreased by 14.7% (13.5 to 15.9). In 2015, 0.40 million people (0.36 million to 0.44 million) died from asthma, a decrease of 26.7% (-7.2 to 43.7) from 1990, and the age-standardised death rate decreased by 58.8% (39.0 to 69.0). The prevalence of asthma increased by 12.6% (9.0 to 16.4), whereas the age-standardised prevalence decreased by 17.7% (15.1 to 19.9). Age-standardised DALY rates due to COPD increased until the middle range of the SDI before reducing sharply. Age-standardised DALY rates due to asthma in both sexes decreased monotonically with rising SDI. The relation between with SDI and DALY rates due to asthma was attributed to variation in years of life lost (YLLs), whereas DALY rates due to COPD varied similarly for YLLs and years lived with disability across the SDI continuum. Smoking and ambient particulate matter were the main risk factors for COPD followed by household air pollution, occupational particulates, ozone, and secondhand smoke. Together, these risks explained 73.3% (95% UI 65.8 to 80.1) of DALYs due to COPD. Smoking and occupational asthmagens were the only risks quantified for asthma in GBD, accounting for 16.5% (14.6 to 18.7) of DALYs due to asthma. Interpretation Asthma was the most prevalent chronic respiratory disease worldwide in 2015, with twice the number of cases of COPD. Deaths from COPD were eight times more common than deaths from asthma. In 2015, COPD caused 2.6% of global DALYs and asthma 1.1% of global DALYs. Although there are laudable international collaborative efforts to make surveys of asthma and COPD more comparable, no consensus exists on case definitions and how to measure disease severity for population health measurements like GBD. Comparisons between countries and over time are important, as much of the chronic respiratory burden is either preventable or treatable with affordable interventions. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Erscheinungsjahr
Zeitschriftentitel
LANCET RESPIRATORY MEDICINE
Band
5
Zeitschriftennummer
9
Seite
691-706
ISSN
PUB-ID

Zitieren

Soriano JB, Abajobir AA, Abate KH, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. LANCET RESPIRATORY MEDICINE. 2017;5(9):691-706.
Soriano, J. B., Abajobir, A. A., Abate, K. H., Abera, S. F., Agrawal, A., Ahmed, M. B., Aichour, A. N., et al. (2017). Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. LANCET RESPIRATORY MEDICINE, 5(9), 691-706. doi:10.1016/S2213-2600(17)30293-X
Soriano, J. B., Abajobir, A. A., Abate, K. H., Abera, S. F., Agrawal, A., Ahmed, M. B., Aichour, A. N., Aichour, I., Aichour, M. T. E., Alam, K., et al. (2017). Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. LANCET RESPIRATORY MEDICINE 5, 691-706.
Soriano, J.B., et al., 2017. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. LANCET RESPIRATORY MEDICINE, 5(9), p 691-706.
J.B. Soriano, et al., “Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015”, LANCET RESPIRATORY MEDICINE, vol. 5, 2017, pp. 691-706.
Soriano, J.B., Abajobir, A.A., Abate, K.H., Abera, S.F., Agrawal, A., Ahmed, M.B., Aichour, A.N., Aichour, I., Aichour, M.T.E., Alam, K., Alam, N., Alkaabi, J.M., Al-Maskari, F., Alvis-Guzman, N., Amberbir, A., Amoako, Y.A., Ansha, M.G., Anto, J.M., Asayesh, H., Atey, T.M., Avokpaho, E.F.G.A., Barac, A., Basu, S., Bedi, N., Bensenor, I.M., Berhane, A., Beyene, A.S., Bhutta, Z.A., Biryukov, S., Boneya, D.J., Brauer, M., Carpenter, D.O., Casey, D., Christopher, D.J., Dandona, L., Dandona, R., Dharmaratne, S.D., Huyen Phuc Do, H.P.D., Fischer, F., Geleto, A., Ghoshal, A.G., Gillum, R.F., Ginawi, I.A.M., Gupta, V., Hay, S.I., Hedayati, M.T., Horita, N., Hosgood, H.D., Jakovljevic, M. (M.) B., James, S.L., Jonas, J.B., Kasaeian, A., Khader, Y.S., Khalil, I.A., Khan, E.A., Khang, Y.-H., Khubchandani, J., Knibbs, L.D., Kosen, S., Koul, P.A., Kumar, G.A., Leshargie, C.T., Liang, X., Abd El Razek, H.M., Majeed, A., Malta, D.C., Manhertz, T., Marquez, N., Mehari, A., Mensah, G.A., Miller, T.R., Mohammad, K.A., Mohammed, K.E., Mohammed, S., Mokdad, A.H., Naghavi, M., Cuong Tat Nguyen, C.T.N., Nguyen, G., Quyen Le Nguyen, Q.L.N., Trang Huyen Nguyen, T.H.N., Ningrum, D.N.A., Vuong Minh Nong, V.M.N., Obi, J.I., Odeyemi, Y.E., Ogbo, F.A., Oren, E., Mahesh, P.A., Park, E.-K., Patton, G.C., Paulson, K., Qorbani, M., Quansah, R., Rafay, A., Rahman, M.H.U., Rai, R.K., Rawaf, S., Reinig, N., Safiri, S., Sarmiento-Suarez, R., Sartorius, B., Savic, M., Sawhney, M., Shigematsu, M., Smith, M., Tadese, F., Thurston, G.D., Topor-Madry, R., Tran, B.X., Ukwaja, K.N., van Boven, J.F.M., Vlassov, V.V., Vollset, S.E., Wan, X., Werdecker, A., Hanson, S.W., Yano, Y., Yimam, H.H., Yonemoto, N., Yu, C., Zaidi, Z., Zaki, M.E.S., Murray, C.J.L., Vos, T.: Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. LANCET RESPIRATORY MEDICINE. 5, 691-706 (2017).
Soriano, Joan B., Abajobir, Amanuel Alemu, Abate, Kalkidan Hassen, Abera, Semaw Ferede, Agrawal, Anurag, Ahmed, Muktar Beshir, Aichour, Amani Nidhal, Aichour, Ibtihel, Aichour, Miloud Taki Eddine, Alam, Khurshid, Alam, Noore, Alkaabi, Juma M., Al-Maskari, Fatma, Alvis-Guzman, Nelson, Amberbir, Alemayehu, Amoako, Yaw Ampem, Ansha, Mustafa Geleto, Anto, Josep M., Asayesh, Hamid, Atey, Tesfay Mehari, Avokpaho, Euripide Frinel G. Arthur, Barac, Aleksandra, Basu, Sanjay, Bedi, Neeraj, Bensenor, Isabela M., Berhane, Adugnaw, Beyene, Addisu Shunu, Bhutta, Zulfiqar A., Biryukov, Stan, Boneya, Dube Jara, Brauer, Michael, Carpenter, David O., Casey, Daniel, Christopher, Devasahayam Jesudas, Dandona, Lalit, Dandona, Rakhi, Dharmaratne, Samath D., Huyen Phuc Do, Huyen Phuc Do, Fischer, Florian, Geleto, Ayele, Ghoshal, Aloke Gopal, Gillum, Richard F., Ginawi, Ibrahim Abdelmageem Mohamed, Gupta, Vipin, Hay, Simon I., Hedayati, Mohammad T., Horita, Nobuyuki, Hosgood, H. Dean, Jakovljevic, Mihajlo (Michael) B., James, Spencer Lewis, Jonas, Jost B., Kasaeian, Amir, Khader, Yousef Saleh, Khalil, Ibrahim A., Khan, Ejaz Ahmad, Khang, Young-Ho, Khubchandani, Jagdish, Knibbs, Luke D., Kosen, Soewarta, Koul, Parvaiz A., Kumar, G. Anil, Leshargie, Cheru Tesema, Liang, Xiaofeng, Abd El Razek, Hassan Magdy, Majeed, Azeem, Malta, Deborah Carvalho, Manhertz, Treh, Marquez, Neal, Mehari, Alem, Mensah, George A., Miller, Ted R., Mohammad, Karzan Abdulmuhsin, Mohammed, Kedir Endris, Mohammed, Shafiu, Mokdad, Ali H., Naghavi, Mohsen, Cuong Tat Nguyen, Cuong Tat Nguyen, Nguyen, Grant, Quyen Le Nguyen, Quyen Le Nguyen, Trang Huyen Nguyen, Trang Huyen Nguyen, Ningrum, Dina Nur Anggraini, Vuong Minh Nong, Vuong Minh Nong, Obi, Jennifer Ifeoma, Odeyemi, Yewande E., Ogbo, Felix Akpojene, Oren, Eyal, Mahesh, P. A., Park, Eun-Kee, Patton, George C., Paulson, Katherine, Qorbani, Mostafa, Quansah, Reginald, Rafay, Anwar, Rahman, Mohammad Hifz Ur, Rai, Rajesh Kumar, Rawaf, Salman, Reinig, Nik, Safiri, Saeid, Sarmiento-Suarez, Rodrigo, Sartorius, Benn, Savic, Miloje, Sawhney, Monika, Shigematsu, Mika, Smith, Mari, Tadese, Fentaw, Thurston, George D., Topor-Madry, Roman, Tran, Bach Xuan, Ukwaja, Kingsley Nnanna, van Boven, Job F. M., Vlassov, Vasiliy Victorovich, Vollset, Stein Emil, Wan, Xia, Werdecker, Andrea, Hanson, Sarah Wulf, Yano, Yuichiro, Yimam, Hassen Hamid, Yonemoto, Naohiro, Yu, Chuanhua, Zaidi, Zoubida, Zaki, Maysaa El Sayed, Murray, Christopher J. L., and Vos, Theo. “Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015”. LANCET RESPIRATORY MEDICINE 5.9 (2017): 691-706.

13 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Need of support in people with chronic obstructive pulmonary disease.
Ali L, Fors A, Ekman I., J Clin Nurs 27(5-6), 2018
PMID: 29149463
Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique.
Blanco I, Diego I, Bueno P, Fernández E, Casas-Maldonado F, Esquinas C, Soriano JB, Miravitlles M., Int J Chron Obstruct Pulmon Dis 13(), 2018
PMID: 29317811
Defining the relationship between COPD and CVD: what are the implications for clinical practice?
Morgan AD, Zakeri R, Quint JK., Ther Adv Respir Dis 12(), 2018
PMID: 29355081
Cost-effectiveness of FreeO2 in patients with chronic obstructive pulmonary disease hospitalised for acute exacerbations: analysis of a pilot study in Quebec.
Poder TG, Kouakou CRC, Bouchard PA, Tremblay V, Blais S, Maltais F, Lellouche F., BMJ Open 8(1), 2018
PMID: 29362258
Factors Associated with Cigarette Smoking and Motivation to Quit among Street Food Sellers in Vietnam.
Le XTT, To LT, Le HT, Hoang HD, Do KN, Nguyen CT, Tran BX, Do HP, Nguyen LT, Latkin CA, Zhang MWB, Ho RCM., Int J Environ Res Public Health 15(2), 2018
PMID: 29382157
Burden of COPD in Nepal.
Adhikari TB, Neupane D, Kallestrup P., Int J Chron Obstruct Pulmon Dis 13(), 2018
PMID: 29445275
Year in review 2017: Chronic obstructive pulmonary disease and asthma.
Benton MJ, Lim TK, Ko FWS, Kan-O K, Mak JCW., Respirology (), 2018
PMID: 29502339
The Trends in Cardiovascular Diseases and Respiratory Diseases Mortality in Urban and Rural China, 1990-2015.
Sun W, Zhou Y, Zhang Z, Cao L, Chen W., Int J Environ Res Public Health 14(11), 2017
PMID: 29140293
Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial.
Janowiak P, Krajnik M, Podolec Z, Bandurski T, Damps-Konstańska I, Sobański P, Currow DC, Jassem E., BMC Pulm Med 17(1), 2017
PMID: 29228935

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 28822787
PubMed | Europe PMC

Suchen in

Google Scholar